J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India flag India · Delayed Price · Currency is INR
2,052.90
-17.50 (-0.85%)
At close: Mar 6, 2026

NSE:JBCHEPHARM Statistics

Total Valuation

NSE:JBCHEPHARM has a market cap or net worth of INR 329.34 billion. The enterprise value is 323.81 billion.

Market Cap 329.34B
Enterprise Value 323.81B

Important Dates

The next estimated earnings date is Friday, May 15, 2026.

Earnings Date May 15, 2026
Ex-Dividend Date Feb 11, 2026

Share Statistics

Current Share Class 160.56M
Shares Outstanding n/a
Shares Change (YoY) -0.27%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 0.13%
Owned by Institutions (%) 30.02%
Float 81.50M

Valuation Ratios

The trailing PE ratio is 43.69 and the forward PE ratio is 36.54.

PE Ratio 43.69
Forward PE 36.54
PS Ratio 7.85
PB Ratio 8.65
P/TBV Ratio 13.31
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 42.96
EV / Sales 7.72
EV / EBITDA 28.23
EV / EBIT 33.98
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA 0.04
Debt / FCF n/a
Interest Coverage 202.55

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 21.85%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 3.87%
Revenue Per Employee 7.91M
Profits Per Employee 1.42M
Employee Count 5,304
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NSE:JBCHEPHARM has paid 2.57 billion in taxes.

Income Tax 2.57B
Effective Tax Rate 25.42%

Stock Price Statistics

The stock price has increased by +24.90% in the last 52 weeks. The beta is -0.07, so NSE:JBCHEPHARM's price volatility has been lower than the market average.

Beta (5Y) -0.07
52-Week Price Change +24.90%
50-Day Moving Average 1,917.64
200-Day Moving Average 1,768.44
Relative Strength Index (RSI) 62.01
Average Volume (20 Days) 330,024

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:JBCHEPHARM had revenue of INR 41.93 billion and earned 7.54 billion in profits. Earnings per share was 47.47.

Revenue 41.93B
Gross Profit 28.11B
Operating Income 9.53B
Pretax Income 10.11B
Net Income 7.54B
EBITDA 11.36B
EBIT 9.53B
Earnings Per Share (EPS) 47.47
Full Income Statement

Balance Sheet

The company has 5.94 billion in cash and 409.10 million in debt, giving a net cash position of 5.53 billion.

Cash & Cash Equivalents 5.94B
Total Debt 409.10M
Net Cash 5.53B
Net Cash Per Share n/a
Equity (Book Value) 38.06B
Book Value Per Share 243.38
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 67.05%, with operating and profit margins of 22.73% and 17.98%.

Gross Margin 67.05%
Operating Margin 22.73%
Pretax Margin 24.10%
Profit Margin 17.98%
EBITDA Margin 27.09%
EBIT Margin 22.73%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 19.70, which amounts to a dividend yield of 0.96%.

Dividend Per Share 19.70
Dividend Yield 0.96%
Dividend Growth (YoY) 29.18%
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield 0.27%
Shareholder Yield 1.23%
Earnings Yield 2.29%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.

Last Split Date Sep 18, 2023
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score 2